Braskem is trading at BRL 4.52, up +6.60%, with no clear company-specific catalyst identified for September 2, 2026.
- Recent coverage highlights strong second-quarter results, including US$1.043 billion in recurring EBITDA, while cautioning that higher spreads were temporary.
- Braskem Idesaβs restructuring remains a major background factor, reducing senior debt from approximately US$2.5 billion to US$1.6 billion.
- The broader market is only mildly higher and does not clearly explain the rally.